Despite the stage migration in prostate cancer noted in this prostate specific antigen (PSA) screening era, extraprostatic disease continues to occur in more than one-third of patients who undergo radical prostatectomy (RP) [1, 2]. The gene discussed is KLK3; the disease is prostate cancer.